Choosing an expression system by what the protein needs rather than by what the laboratory owns: why baculovirus protein expression in insect cells handles large, multi domain and membrane proteins that bacteria will not fold, what mammalian expression vectors give in human like modification and cost in time and yield, where chemically competent e coli and a dh5 alpha strain sit as cloning hosts rather than expression ones, why an expression strain is chosen for protease deficiency and repression instead, what a reporter gene assay adds as a functional readout of an expression construct, and what has to be measured before a system is declared to work

Expression systems are chosen by what the protein cannot do without: disulphide bonds, glycosylation, membrane insertion or simply size. Bacteria are fastest and least capable; insect cells handle complexity at moderate cost; mammalian cells give human like processing slowly and expensively.

the biosafety manual that decides handling for biological material
BMBL
good laboratory practice for nonclinical studies, 21 CFR
Part 58
the labelling clause behind research use only on a reagent
809.10(c)

The figures in this panel are regulation and standard identifiers, named from the documents themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a price index it has not measured.

Choosing the route

  1. List the modifications the protein requires. Disulphide bonding, glycosylation, phosphorylation and membrane insertion each rule systems in or out. That list, written first, selects the host without further debate.
  2. Separate cloning hosts from expression hosts. A high efficiency cloning strain is optimised for uptake and plasmid stability, not for expressing protein without degrading it. Using one to express is a common quiet failure.
  3. Budget the insect system's timeline honestly. Generating and amplifying virus adds weeks before any protein appears, and titre has to be tracked. The capability is real and it is not fast.
  4. Choose the mammalian route for human like product. Transient expression gives milligrams in weeks; stable lines give more, later. Both cost considerably more per milligram than the alternatives and are the only route for some proteins.
  5. Use a reporter to validate the construct. A reporter in the same vector confirms transcription, translation and delivery independently of whether your protein folds. It separates construct problems from protein problems.
  6. Characterise before declaring success. Yield, purity, aggregation state and activity. A system that gives high yield of misfolded protein has not worked, and only the activity measurement reveals it.

Yield is not the objective

A system that produces large amounts of insoluble or misfolded protein has not solved the problem. The measurement that matters is active, correctly folded protein per unit of effort.

Include an activity assay in the screen from the start, not after purification. It changes which conditions look best.

Screen in parallel, not in series

Host, construct boundaries, tag position and temperature interact, and testing them one at a time takes a quarter. Small parallel screens answer in a week.

It is the highest return activity in the whole workflow and the one most often skipped under time pressure.

Common questions

When should I move beyond bacterial expression?
When the protein needs glycosylation, complex disulphide bonding, membrane insertion or is large and multi domain. Those are folding requirements that induction conditions cannot fix.
Why not use a cloning strain to express?
Because it lacks protease deficiency and tight repression, so the protein is degraded or the construct is lost. Expression strains exist for exactly those properties.
How long does an insect cell campaign take?
Weeks before protein appears, because virus has to be generated, amplified and titred first. It is a capable system and it should not be chosen when speed is the constraint.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/baculovirus-protein-expression/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices